Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization-Reference-Cited by-同舟云学术

Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization

Published:2020 Issue:23 Volume:8 Page:5143-5154
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Han Haijie¹²³⁴⁵,Yin Qichuan¹²³⁴⁵,Tang Xiajing¹²³⁴⁵,Yu Xiaoning¹²³⁴⁵,Gao Qiang⁶⁷⁴⁸⁹,Tang Yelei¹⁰¹¹³⁴⁵,Grzybowski Andrzej¹²¹³¹⁴¹⁵¹⁶,Yao Ke¹²³⁴⁵,Ji Jian⁶⁷⁴⁸⁹^ORCID,Shentu Xingchao¹²³⁴⁵

Affiliation:

1. Zhejiang Provincial Key Lab of Ophthalmology

2. Eye Center, the Second Affiliated Hospital

3. School of Medicine

4. Zhejiang University

5. Hangzhou 310009

6. MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education

7. Department of Polymer Science and Engineering

8. Hangzhou 310027

9. P. R. China

10. Department of Neurology

11. The Second Affiliated Hospital

12. Department of Ophthalmology

13. University of Warmia and Mazury

14. 60-554 Olsztyn

15. Poland

16. Institute for Research in Ophthalmology

Abstract

A simple and safe administration for effective inhibition of corneal neovascularization through cationic polypeptide micelles loaded with a tyrosine kinase inhibitor, cabozantinib.

Funder

Natural Science Foundation of Zhejiang Province

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2020/TB/D0TB00874E

Reference46 articles.

1. Current and emerging therapies for corneal neovascularization